– Ciitizen real-world data platform expansion helps advance research and potentially improve outcomes for patients with pediatric epilepsy and/or developmental delay – SAN FRANCISCO, Dec. 1, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the...
News Ticker
- [ March 29, 2023 ] Biomea goes for $125M offering after early diabetes data nearly doubled stock price News
- [ March 29, 2023 ] NextFlex Announces 2023 Fellows Awards for Two Exceptional Recipients News
- [ March 29, 2023 ] No longer ‘dead or just hibernating,’ drugmakers return to heart medicines News
- [ March 29, 2023 ] Nevro to Report First Quarter 2023 Financial Results News
- [ March 29, 2023 ] SamaCare Partners with AmerisourceBergen to Offer Prior Authorization Platform to Specialty Practices News
Copyright © 2022 Biotech Networks, LLC
